Glycaemic control and perioperative organ protection

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 1, 2008, Pages 135-149

  Berkers, Joost ^a   Gunst, Jan ^a   Vanhorebeek, Ilse ^a   Van den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

critical illness; hyperglycaemia; insulin; morbidity; mortality

Indexed keywords

ANTIBIOTIC AGENT; GLUCOSE; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; ANEMIA; ARTIFICIAL VENTILATION; BACTEREMIA; BRAIN INJURY; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; ERYTHROCYTE TRANSFUSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LENGTH OF STAY; MORBIDITY; MORTALITY; NONHUMAN; PARENTERAL NUTRITION; PERIOPERATIVE PERIOD; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; STRESS; SURVIVAL RATE;

CRITICAL CARE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; INTRAOPERATIVE COMPLICATIONS; LENGTH OF STAY; MULTICENTER STUDIES AS TOPIC; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 40949160900     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2007.08.002     Document Type: Review

References (88)

1. Thorell A., Nygren J., and Ljungqvist O. Insulin resistance: a marker of surgical stress. Current Opinion in Clinical Nutrition and Metabolic Care 21 (1999) 69-78
2. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycaemia. Critical Care Clinics 17 (2001) 107-124
3. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine 345 (2001) 1359-1367
4. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Critical Care Medicine 31 (2003) 359-366
5. Hill M., and McCallum R. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. The Journal of Clinical Investigation 88 (1991) 811-816
6. Khani S., and Tayek J.A. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clinical Science (London,England:1979) 101 (2001) 739-747
7. Watt M.J., Howlett K.F., Febbraio M.A., et al. Adrenalin increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. The Journal of Physiology 534 (2001) 269-278
8. Flores E.A., Istfan N., Pomposelli J.J., et al. Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. Metabolism 39 (1990) 738-743
9. Sakurai Y., Zhang X.J., and Wolfe R.R. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. The American Journal of Physiology 270 (1996) E864-E872
10. Lang C.H., Dobrescu C., and Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130 (1992) 43-52
11. Wolfe R.R., Durkot M.J., Allsop J.R., et al. Glucose metabolism in severely burned patients. Metabolism 28 (1979) 1031-1039
12. Wolfe R.R., Herndon D.N., Jahoor F., et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. The New England Journal of Medicine 317 (1987) 403-408
13. Mizock B.A. Alterations in carbohydrate metabolism during stress: a review of the literature. The American Journal of Physiology 98 (1995) 75-84
14. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
15. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 (2001) 2426-2432
16. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 (2000) 335-342
17. Jeremitsky E., Omert L.A., Dunham M., et al. The impact of hyperglycemia on patients with severe brain injury. The Journal of Trauma 58 (2005) 47-50
18. Yendamuri S., Fulda G.J., and Tinkoff G.H. Admission hyperglycemia as a prognostic indicator in trauma. The Journal of Trauma 55 (2003) 33-38
19. Laird A.M., Miller P.R., Kilgo P.D., et al. Relationship of early hyperglycemia to mortality in trauma patients. The Journal of Trauma 56 (2004) 1058-1062
20. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings. Mayo Clinic 78 (2003) 1471-1478
21. Faustino E.V., and Apkon M. Persistent hyperglycemia in critically ill children. The Journal of Pediatrics 146 (2005) 30-34
22. Gore D.C., Chinkes D., Heggers J., et al. Association of hyperglycemia with increased mortality after severe burn injury. The Journal of Trauma 51 (2001) 540-544
23. Ingels C., Debaveye Y., Milants I., et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-year survival, dependency on medical care, and quality-of-life. European Heart Journal 27 (2006) 2716-2724
24. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings. Mayo Clinic 79 (2004) 992-1000
25. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354 (2006) 449-461
26. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units. benefit versus harm. Diabetes 55 (2006) 3151-3159
27. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Annals of Internal Medicine 146 (2007) 233-243
28. Van den Berghe G. Does tight blood glucose control during cardiac surgery improve patient outcome?. Annals of Internal Medicine 146 (2007) 307-308
29. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
30. Hermans G., Wilmer A., Meersseman W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. American Journal of Respiratory and Critical Care Medicine 175 5 (2007) 480-489
31. Grey N.J., and Perdrizet G.A. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocrine Practice 10 supplementry 2 (2004) 46-52
32. Pittas A.G., Stegel R.D., and Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 164 (2004) 2005-2011
33. Mehta S.R., Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. Journal of the American Medical Association 293 (2005) 437-446
34. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. Journal of the American College of Cardiology 26 (1995) 57-65
35. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) study group. BMJ(Clinical Research Ed.) 314 (1997) 1512-1515
36. Malmberg K., Ryden L., Hamsten A., et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. European Heart Journal 17 (1996) 1337-1344
37. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European Heart Journal 26 (2005) 650-661
38. Scott J.F., Robinson G.M., French J.M., et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 30 (1999) 793-799
39. Brunkhorst F.M., Kuhnt E., Engel C., et al. Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an increased rate of hypoglycemia - results from a randomized multicenter study (VISEP). [abstract]. Infection 33 supplementry 1 (2005) 19
40. http://webanae.med.unijena.de/WebObjects/DSGPortal.woa/WebServerResources/sepnet/visep.html
41. National Institutes of Health. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. Available from http://www.clinicaltrials.gov/ct/show/NCT00107601 and http://www.glucontrol.org/
42. Clinicaltrials.gov. Normoglycemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR study) [accessed May 13, 2007], at http://www.clinicltrials.gov/ct/show/NCT00220987)
43. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelies for management of severe sepsis and septic shock. Critical Care Medicine 32 (2004) 858-873
44. Boord J.B., Graber A.L., Christman J.W., et al. Practical management of diabetes in critically ill patients. American Journal of Respiratory and Critical Care Medicine 164 (2001) 1763-1767
45. Vriesendorp T.M., De Vries J.H., van Santen S., et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Critical Care Medicine 34 (2006) 2714-2718
46. Mackenzie I., Ingle S., Zaidi S., et al. Hypoglycemia? So what!. Intensive Care Medicine 32 (2006) 620-621
47. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. Journal of the American Medical Association 290 (2003) 2041-2047
48. Jolliet P., Pichard C., Biolog G., et al. Enteral nutrition in intensive care patients: a practical approach. Intensive Care Medicine 24 (1998) 848-859
49. Kanji S., Buffie J., Hutton B., et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Critical Care Medicine 33 (2005) 2778-2785
50. Vlasselaers D., Schaupp L., van den Heuvel I., et al. Monitoring blood glucose with microdialysis of interstitial fluid in critically ill children. Clinical Chemistry 53 (2007) 1-2
51. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. The Journal of Clinical Investigation 114 (2004) 1187-1195
52. Vanhorebeek I., and Van den Berghe G. The diabetes of injury: novel insights. Endocrinology and Metabolism Clinics of North America 35 (2006) 859-872
53. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness. Diabetes 55 (2006) 1096-1105
54. Klip A., Tsakiridis T., Marette A., and Ortiz P.A. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. The FASEB Journal 8 (1994) 43-53
55. Pekala P., Marlow M., Heuvelman D., and Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor alfa, but not by insulin. The Journal of Biological Chemistry 265 (1990) 18051-18054
56. Shikhman A.R., Brinson D.C., Valbracht J., and Lotz M.K. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. Journal of Immunology 167 (2001) 7001-7008
57. Quinn L.A., and McCumbee W.D. Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. Journal of Cellular Physiology 177 (1998) 94-102
58. Clerici C., and Matthay M.A. Hypoxia regulates gene expression of alveolar epithelial transport proteins. Journal of Applied Physiology 88 (2000) 1890-1896
59. Sanchez-Alvarez R., Tabernero A., and Medina J.M. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. Journal of Neurochemistry 89 (2004) 703-714
60. Tirone T.A., and Brunicardi C. Overview of glucose regulation. World Journal of Surgery 25 (2001) 461-467
61. Vanhorebeek I., De Vos R., Mesotten D., et al. Strict blood glucose control with insulin in critically ill patients protects hepatocytic mitochondrial ultrastructure and function. Lancet 365 (2005) 53-59
62. Rassias A.J., Marrin C.A., Arruda J., et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia 88 (1999) 1011-1016
63. Nielson C.P., and Hindson D.A. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38 (1989) 1031-1035
64. Perner A., Nielsen S.E., and Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Medicine 29 (2003) 642-645
65. Rayfield E.J., Ault M.J., Keusch G.T., et al. Infection and diabetes: the case for glucose control. The American Journal of Medicine 72 (1982) 439-450
66. Pozzili P., and Leslie R.D. Infections and diabetes: mechanisms and prospects for prevention. Diabetic medicine: A Journal of the British Diabetic Association 11 (1994) 935-941
67. Weekers F., Van Herck E., Coopmans W., et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a bi-phasic neuroendocrine stress response. Endocrinology 143 (2002) 764-774
68. Weekers F., Giuletti A., Michalaki M., et al. Endocrine and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
69. Lanza-Jacoby S., Wong S.H., Tabares A., et al. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochimica et Biophysica Acta 1124 (1992) 233-240
70. Khovidhunkit W., Memon R.A., Feingold K.R., and Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. The Journal of Infectious Diseases 181 (2000) S462-S472
71. Carpentier Y.A., and Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Current Opinion in Clinical Nutrition and Metabolic Care 5 (2002) 153-158
72. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 219-226
73. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Annals of Surgery 239 (2004) 553-560
74. Gore D.C., Wolf S.E., Sanford A.P., et al. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. American Journal of Physiology. Endocrinology and Metabolism 286 (2004) E529-E534
75. Agus M.S.D., Javid P.J., Ryan D.P., and Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. Journal of Pediatric Surgery 39 (2004) 839-844
76. Zhang X.J., Chinkes D.L., Irtun O., and Wolfe R.R. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. American Journal of Physiology. Endocrinology and metabolism 282 (2002) E1308-E1315
77. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation 155 (2005) 2277-2286
78. Siroen M.P.C., van Leeuwen P.A.M., Nijveldt R.J., et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Critical Care Medicine 33 (2005) 504-510
79. Nijveldt R.J., Teerlink T., and van Leeuwen P.A. The asymmetric dimethylarginine (ADMA)-multiple organ failure hypothesis. Clinical Nutrition 22 (2003) 99-104
80. Das U.N. Insulin: an endogenous cardioprotector. Current Opinion in Critical Care 9 (2003) 375-383
81. Gao F., Gao E., Yue T., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the role of PI3-kinase, Akt and eNOS phosphorylation. Circulation 105 (2002) 1497-1502
82. Jonassen A., Sack M., Mjos O., and Yellon D. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signalling. Circulation Research 89 (2001) 1191-1198
83. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients, as indicated by circulating mannose-binding lectin and C-reactive protein levels. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 1082-1088
84. Jeschke M.G., Klein D., Bolder U., and Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145 (2004) 4084-4093
85. Klein D., Schubert T., Horch R.E., et al. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Annals of Surgery 240 (2004) 340-349
86. Brix-Christensen V., Andersen S.K., Andersen R., et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology 100 (2004) 861-870
87. Vanhorebeek I., Peeters R.P., Vander Perre S., et al. Cortisol response to critical illness: effect of intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 3803-3813
88. Inzucchi S.E. Management of hyperglycemia in the hospital setting. The New England Journal of Medicine 355 (2006) 1903-1911